Trial
NCT02608229
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Washington University School of Medicine
Collaborators
BioMed Valley Discoveries, Inc; National Cancer Institute (NCI)
Condition
Pancreatic Cancer
Intervention
BVD-523
Why stopped
Adverse events
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-21